A Phase 1 Dose Escalation Study of AMG 780 in Adult Subjects With Advanced Solid Tumor

This study is currently recruiting participants.
Verified July 2012 by Amgen
Sponsor:
Information provided by (Responsible Party):
Amgen
ClinicalTrials.gov Identifier:
NCT01137552
First received: April 22, 2010
Last updated: July 12, 2012
Last verified: July 2012
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study is currently recruiting participants.
  Estimated Study Completion Date: April 2013
  Estimated Primary Completion Date: December 2012 (Final data collection date for primary outcome measure)